Profusa Registers 179 Million Shares for Resale, Signaling Nearly 4000% Potential Dilution Amid Financial Distress

summarizeSummary

Profusa filed an S-1 to register 179.3 million shares for resale, representing a potential dilution of nearly 4000% for current shareholders, as the company continues to rely on highly dilutive financing amidst severe financial challenges and delisting threats.

check_boxKey Events

• Massive Potential Dilution

  The S-1 registers 179,272,293 shares for resale, which, if fully issued, would increase the outstanding share count from 4,410,268 to 180,349,228, representing a potential dilution of approximately 3989% for existing shareholders.

• Expansion of Dilutive Financing Programs

  This registration includes an additional 150,568,827 shares for the existing Equity Line of Credit (ELOC) with Ascent, along with shares from convertible notes and inducement warrants, indicating continued reliance on highly dilutive capital raises.

• Low Conversion and Exercise Prices

  Shares from convertible notes and warrants are convertible/exercisable at prices as low as $0.35 to $0.50 per share, significantly below the current market price of $0.5166, further exacerbating dilution.

• Company's Dire Financial State

  This dilutive financing occurs in the context of a recent 10-K filing revealing a going concern warning, zero revenue, and ongoing Nasdaq delisting proceedings, highlighting the company's critical need for capital.

auto_awesomeAnalysis

Profusa, a company already facing a going concern warning and Nasdaq delisting threats, has filed an S-1 registration statement for the resale of up to 179,272,293 shares of common stock. This includes shares issuable under an existing Equity Line of Credit (ELOC) with Ascent Partners Fund LLC, convertible notes held by Ascent and NorthView Sponsor I, LLC, and inducement warrants. With only 4,410,268 shares currently outstanding, the full issuance of these registered shares would result in a staggering potential dilution of approximately 3989% for existing shareholders. While the company may receive up to $100 million from future sales under the ELOC and $1.67 million from warrant exercises, the primary purpose of this registration is to allow existing investors to resell their shares, not for the company to raise capital directly from the public for most of these shares. The low conversion and exercise prices of the underlying securities (as low as $0.35-$0.50 per share compared to the current $0.5166) highlight the highly dilutive nature of these financing arrangements, underscoring the company's urgent need for capital to sustain operations.